Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LL
3301
DELISTED
LL Flooring Holdings, Inc.
LL
| $2.28M | ﹤0.01% |
594,024
+233,523
| +65% | +$903K |
|
3302
ESCO Technologies
ESE
$7.18B
| $2.27M | ﹤0.01% |
21,952
+9,062
| +70% | +$871K |
|
3303
PUT
PennyMac Financial
PFSI
$3.81B
| $2.27M | ﹤0.01% |
+32,300
| New | +$2.05M |
|
3304
Vanguard FTSE All-World ex-US ETF
VEU
$70.4B
| $2.27M | ﹤0.01% |
41,647
-63,913
| -61% | -$3.46M |
|
3305
CALL
HF Sinclair
DINO
$17.7B
| $2.26M | ﹤0.01% |
+50,700
| New | +$2.21M |
|
|
3306
PUT
HF Sinclair
DINO
$17.7B
| $2.26M | ﹤0.01% |
50,700
-20,300
| -29% | -$884K |
|
3307
Upwork
UPWK
$1.13B
| $2.26M | ﹤0.01% |
242,066
-44,135
| -15% | -$400K |
|
3308
Prothena Corp
PRTA
$479M
| $2.26M | ﹤0.01% |
33,100
-161,539
| -83% | -$10.4M |
|
|
PGRE
3309
DELISTED
Paramount Group
PGRE
| $2.26M | ﹤0.01% |
510,074
+468,351
| +1,123% | +$2.08M |
|
3310
CALL
Surgery Partners
SGRY
$1.79B
| $2.25M | ﹤0.01% |
+50,000
| New | +$1.91M |
|
3311
CALL
Revolution Medicines
RVMD
$44.6B
| $2.25M | ﹤0.01% |
+84,000
| New | +$2.06M |
|
3312
Sonoco
SON
$5.58B
| $2.24M | ﹤0.01% |
37,928
+19,504
| +106% | +$1.17M |
|
|
YMAB
3313
DELISTED
Y-mAbs Therapeutics
YMAB
| $2.24M | ﹤0.01% |
329,569
-293,522
| -47% | -$2.2M |
|
3314
Pathward Financial
CASH
$1.69B
| $2.23M | ﹤0.01% |
48,155
-12,679
| -21% | -$569K |
|
3315
Ituran Location and Control
ITRN
$1B
| $2.23M | ﹤0.01% |
95,593
+28,045
| +42% | +$632K |
|
3316
CALL
Dollar General
DG
$27.1B
| $2.22M | ﹤0.01% |
13,100
-69,600
| -84% | -$13.8M |
|
|
WBA
3317
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $2.22M | ﹤0.01% |
78,000
-437,200
| -85% | -$14.2M |
|
3318
Atmus Filtration Technologies
ATMU
$3.89B
| $2.22M | ﹤0.01% |
+101,183
| New | +$2.12M |
|
|
FRBN
3319
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
| $2.22M | ﹤0.01% |
207,000
| – | – |
|
3320
Albemarle
ALB
$16.2B
| $2.22M | ﹤0.01% |
9,941
-439,745
| -98% | -$89.9M |
|
3321
PUT
Bruker
BRKR
$8.7B
| $2.22M | ﹤0.01% |
30,000
| – | – |
|
3322
Aon
AON
$75.4B
| $2.22M | ﹤0.01% |
6,422
-101,100
| -94% | -$32.8M |
|
3323
BILL Holdings
BILL
$5.01B
| $2.22M | ﹤0.01% |
18,970
+680
| +4% | +$64.6K |
|
3324
Goosehead Insurance
GSHD
$1.7B
| $2.22M | ﹤0.01% |
35,240
-75,846
| -68% | -$4.36M |
|
3325
AAR Corp
AIR
$5.36B
| $2.22M | ﹤0.01% |
38,366
-8,428
| -18% | -$454K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.